Loading...
Please wait, while we are loading the content...
Similar Documents
Multi-institutional, prospective, observational study comparing the Gastrografin challenge versus standard treatment in adhesive small bowel obstruction.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Zielinski, Martin Donald Haddad, Nadeem N. Cullinane, Daniel C. Inaba, Kenji Yeh, Dante D. Wydo, Salina M. Turay, David Pakula, Andrea M. Duane, Therese Marie Watras, Jill Widom, Kenneth A. Cull, John David Rodríguez, Carlos Javier Acurio Toschlog, Eric A. Sams, Valerie G. Hazelton, Joshua P. Graybill, John Christopher Skinner, Ruby A. Yune, Ji-Ming |
| Copyright Year | 2017 |
| Abstract | INTRODUCTION Existing trials studying the use of Gastrografin for management of adhesive small bowel obstruction (SBO) are limited by methodological flaws and small sample sizes. We compared institutional protocols with and without Gastrografin (GG), hypothesizing that a SBO management protocol utilizing GG is associated with lesser rates of exploration, shorter length of stay, and fewer complications. METHODS A multi-institutional, prospective, observational study was performed on patients appropriate for GG with adhesive SBO. Exclusion criteria were internal/external hernia, signs of strangulation, history of abdominal/pelvic malignancy, or exploration within the past 6 weeks. Patients receiving GG were compared to patients receiving standard care without GG. RESULTS Overall, 316 patients were included (58 ± 18 years; 53% male). There were 173 (55%) patients in the GG group (of whom 118 [75%] successfully passed) and 143 patients in the non-GG group. There were no differences in duration of obstipation (1.6 vs. 1.9 days, p = 0.77) or small bowel feces sign (32.9% vs. 25.0%, p = 0.14). Fewer patients in the GG protocol cohort had mesenteric edema on CT (16.3% vs. 29.9%; p = 0.009). There was a lower rate of bowel resection (6.9% vs. 21.0%, p < 0.001) and exploration rate in the GG group (20.8% vs. 44.1%, p < 0.0001). GG patients had a shorter duration of hospital stay (4 IQR 2-7 vs. 5 days IQR 2-12; p = 0.036) and a similar rate of complications (12.5% vs. 17.9%; p = 0.20). Multivariable analysis revealed that GG was independently associated with successful nonoperative management. CONCLUSION Patients receiving Gastrografin for adhesive SBO had lower rates of exploration and shorter hospital length of stay compared to patients who did not receive GG. Adequately powered and well-designed randomized trials are required to confirm these findings and establish causality. LEVEL OF EVIDENCE Therapeutic, level III. |
| Starting Page | 47 |
| Ending Page | 54 |
| Page Count | 8 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://www.east.org/content/documents/01_zielinski_multi-institutional_prospective_observational.pdf |
| PubMed reference number | 28422909v1 |
| Alternate Webpage(s) | https://doi.org/10.1097/TA.0000000000001499 |
| DOI | 10.1097/TA.0000000000001499 |
| Journal | The journal of trauma and acute care surgery |
| Volume Number | 83 |
| Issue Number | 1 |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Abdominal Abscess Adhesives Constipation Death by strangulation Excision Feces Gastrografin Intestinal Obstruction Intestines Intestines, Small Mesentery Neoplasms Non-Small Cell Lung Carcinoma Numerous Patients Protocols documentation Pulmonary Edema Sample Size Small Intestinal Wall Tissue Small bowel obstruction bowel resection |
| Content Type | Text |
| Resource Type | Article |